OSAM
MRNA icon

O'Shaughnessy Asset Management’s Moderna MRNA Stock Holding History

O'Shaughnessy Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Sell
21,479
-1,972
-8% -$102K 0.01% 1054
2026
Q1 		$1.19M Buy
23,451
+11,956
+104% +$558K 0.01% 1097
2025
Q4 		$339K Buy
11,495
+2,288
+25% +$62.2K ﹤0.01% 1705
2025
Q3 		$238K Sell
9,207
-1,285
-12% -$35.8K ﹤0.01% 1875
2025
Q2 		$289K Buy
+10,492
New +$276K ﹤0.01% 1655
2024
Q4 		– Sell
-9,418
Closed -$544K – 2259
2024
Q3 		$544K Sell
9,418
-9,982
-51% -$916K ﹤0.01% 1192
2024
Q2 		$2.3M Buy
19,400
+8,531
+78% +$1.08M 0.02% 560
2024
Q1 		$1.16M Buy
10,869
+3,148
+41% +$317K 0.01% 772
2023
Q4 		$768K Buy
7,721
+57
+0.7% +$4.79K 0.01% 839
2023
Q3 		$792K Buy
7,664
+1,945
+34% +$217K 0.01% 762
2023
Q2 		$695K Buy
5,719
+33
+0.6% +$4.4K 0.01% 768
2023
Q1 		$873K Sell
5,686
-3,839
-40% -$633K 0.01% 693
2022
Q4 		$1.71M Buy
9,525
+5,556
+140% +$908K 0.03% 461
2022
Q3 		$469K Buy
3,969
+139
+4% +$21.1K 0.01% 759
2022
Q2 		$547K Sell
3,830
-500
-12% -$71.5K 0.01% 667
2022
Q1 		$746K Buy
4,330
+934
+28% +$157K 0.01% 614
2021
Q4 		$863K Sell
3,396
-436
-11% -$127K 0.02% 543
2021
Q3 		$1.48M Buy
3,832
+2,073
+118% +$765K 0.03% 380
2021
Q2 		$413K Buy
1,759
+746
+74% +$133K 0.01% 734
2021
Q1 		$133K Buy
1,013
+279
+38% +$40.4K ﹤0.01% 1082
2020
Q4 		$77K Buy
734
+621
+550% +$62.8K ﹤0.01% 1142
2020
Q3 		$8K Buy
113
+4
+4% +$279 ﹤0.01% 1408
2020
Q2 		$7K Buy
+109
New +$5.97K ﹤0.01% 1323
2019
Q3 		– Sell
-1
Closed – – 1144
2019
Q2 		$0 Buy
+1
New +$21 ﹤0.01% 1134

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

O'Shaughnessy Asset Management's MRNA Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Moderna (MRNA) stake by 8.4% in Q2 2026, selling an estimated $102K and leaving 21,479 shares worth $1.5M. The position accounts for 0.01% of the portfolio, ranked #1054.

O'Shaughnessy Asset Management first reported a position in MRNA in Q2 2019 and has held it in 24 quarters since. The position peaked at $2.3M in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • O'Shaughnessy Asset Management held 21,479 shares of Moderna worth $1.5M as of Q2 2026.
  • O'Shaughnessy Asset Management sold 1,972 Moderna shares in Q2 2026, an estimated $102K.
  • Moderna made up 0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1054 holding.
  • O'Shaughnessy Asset Management first reported a position in Moderna in Q2 2019 and has held it in 24 quarters since.
  • O'Shaughnessy Asset Management's Moderna position peaked at $2.3M in Q2 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.